Why Cannabis Investors Should Make This Bold Move Before Florida's Vote: What To Buy And Sell Now

Florida’s upcoming vote on recreational cannabis has set the investment world abuzz, with strategic opportunities awaiting discerning investors. The renowned Viridian Credit Tracker deems AYR Wellness (AYRWF) a robust buy, sporting an enticing 20% yield, courtesy of its strong footprint in Florida’s cannabis sector. AYR’s fortunes could skyrocket if recreational cannabis gets the nod in Florida, making it a luscious target for investors eyeing pre-vote maneuvers.

AYR Wellness Offers 20% Yield: Capitalize on Florida’s Potential Vote

The Viridian Credit Tracker singles out AYR Wellness for its Florida-centric approach, a boon as the state considers recreational cannabis legalization. With a tempting 20% yield, AYR outshines many peers, positioned for a considerable upswing if Florida gives the green light to recreational use.

Cresco Labs vs. Curaleaf: A 250 Basis Point Difference

Viridian suggests a savvy trade: buy into Cresco Labs (CRLBF) at a 12.6% yield and offload Curaleaf (CURLF) at 10.1%. This switcheroo offers a 250 basis point yield bump, thanks to Cresco’s robust financials and credit progress. Those hungry for richer returns and sturdier credit profiles should ponder this tantalizing opportunity.

TerrAscend: Why 12% Yield Might Not Be Enough

In a divergent move, TerrAscend (TRSSF) and its 12% yield are pegged as a sell recommendation. Despite its industry clout, TerrAscend lags due to its lower yield and limited exposure to Florida’s growth prospects, making it less appetizing compared to AYR.

Cannabist Faces Liquidity Challenges

Among top contenders, Cannabist (CCHWF) bears the weakest credit, primarily due to liquidity woes stemming from recent asset sales. Investors take heed: Cannabist’s feeble credit rating may hamper imminent upside, even as prospects could brighten down the road.

Take Action Now: Florida’s Vote Could Change the Game

With Florida’s cannabis realm on the brink of expansion, shrewd investors should mull over this move: seize AYR at 20%, shed TerrAscend at 12%, and explore Cresco Labs at 12.6% vis-à-vis Curaleaf at 10.1%. The vote’s fallout could be a game-changer for cannabis equities, beckoning lucrative returns if one acts precociously.

Read Next: SEC Charges ‘Magic Mushroom’ Co. Minerco In $8M Pump-And-Dump Scheme